Tevogen (TVGN) Director Feike Jeffrey L. Receives Award

What Happened

• Feike Jeffrey L., a director of Tevogen Inc. (TVGN), was granted 75,000 restricted shares on September 11, 2026. The award was granted at $0.00 per share (total value reported as $0 at grant), i.e., this is a restricted stock award rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-09-11; Form 4 filed: 2026-09-15 (Accession No. 0001123292-26-001304). The filing appears timely under the two-business-day rule.
• Price: $0.00 per share; total reported cash consideration = $0.
• Shares acquired: 75,000 restricted shares (award/grant — transaction code A).
• Shares owned after transaction: Not disclosed in the provided excerpt.
• Footnote: The grant is under the Tevogen Inc. 2024 Omnibus Incentive Plan and "will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service" (footnote F1).
• No indication of a 10b5-1 plan, tax‑withholding sale, or immediate sale of shares in this filing.

Context

• This is a restricted stock award (compensation) rather than a purchase or sale; such awards are common for directors and generally vest over time, tying compensation to continued service.
• Because the award vests in future installments, the shares are not fully owned or freely tradable until vesting conditions are met. This is not an immediate market activity signal like an open‑market buy or sell.